Neuroaxonal Dystrophy in Dogs: Causes, Signs & Care

Neuroaxonal dystrophy (NAD) in dogs is an uncommon inherited neurodegenerative disorder affecting the nervous system, leading to swelling and breakdown of nerve cells in the brain and spinal column. This progressive illness gradually impairs neurological function, undermining a dog's coordination, balance, and sensory abilities, often resulting in severe health challenges.

What is Neuroaxonal Dystrophy?

Neuroaxonal dystrophy stems from a genetic mutation inherited in an autosomal recessive manner, meaning the dog must receive the defective gene from both parents to develop the disease. Research also suggests that NAD might occasionally develop secondary to vitamin E deficiencies, toxin exposure, or aging-related nerve degeneration, but its primary cause remains genetic.

Breeds Most Vulnerable to NAD in the U.S.

Though NAD is rare, it is documented more frequently in specific dog breeds within the United States. Notably susceptible breeds include:

• Border Collie puppies
• Chihuahua puppies
• Jack Russell Terrier puppies
• Labrador Retriever puppies
• Papillon puppies
• Rottweiler puppies
• Giant Schnauzer puppies

In addition to these, NAD has been sporadically reported in crossbreeds, emphasizing the importance of genetic awareness and testing.

Identifying Symptoms of NAD

Early signs typically involve chronic ataxia, which shows as an unsteady, uncoordinated walk affecting all four limbs, progressively worsening. Dogs may also show hypermetria—overreaching or misjudging stepping distances. Other symptoms include tremors, cerebellar dysfunction (such as involuntary eye movements known as nystagmus), muscle weakness, and cognitive changes decreasing environmental awareness.

For example, in Rottweilers, symptoms often become noticeable as early as a few months of age, while in Border Collies, signs usually develop closer to one year old.

How is Neuroaxonal Dystrophy Diagnosed in the U.S.?

Diagnosing NAD during a dog’s lifetime poses challenges. American veterinarians primarily rely on clinical neurological examinations, supported by ruling out alternative conditions such as infectious diseases or metabolic disorders through blood work and imaging. Advanced techniques include MRI and CT scans of the brain and spinal cord to reveal neurodegenerative changes.

When available, genetic testing is crucial for predisposed breeds, particularly for known mutations such as PLA2G6 identified in Papillons. Definitive confirmation often requires post-mortem brain tissue analysis to detect characteristic axonal swellings called spheroids.

Treatment and Management

Currently, no cure or widely effective treatment exists for NAD. Care focuses on supportive approaches to improve comfort and quality of life. This includes:

• Providing a comfortable, safe living environment to help with mobility challenges
• Using anti-inflammatory medications like carprofen or prednisone to reduce inflammation
• Administering muscle relaxants such as methocarbamol to ease muscle spasms
• Regular monitoring and assistance to prevent injuries due to coordination loss

Breeders play a vital role in preventing NAD by employing genetic testing protocols to avoid breeding dogs carrying the defective genes.

Understanding the Prognosis

The prognosis for dogs diagnosed with NAD is unfortunately guarded. This neurodegenerative disease generally progresses steadily, often resulting in paralysis, vision loss, and severe neurological decline. Most affected dogs face a rapidly deteriorating health trajectory after symptoms appear.

Supporting Dogs and Their Families Affected by NAD

Receiving a NAD diagnosis can be overwhelming and heartbreaking for American dog owners. Compassionate guidance and thorough education are essential. Collaborating closely with veterinarians and veterinary neurologists helps owners make informed care decisions and explore palliative options to maximize their pet’s comfort.

For those looking to add a dog to their family, it’s key to select reputable breeders who routinely perform genetic screening to reduce inherited conditions like NAD. Adopting from established U.S. rescue organizations also supports ethical pet ownership and provides dogs with a second chance.